MSN Laboratories Private Limited — Capecitabine Exporter Profile
Indian Pharmaceutical Exporter · #3 for Capecitabine · $7.4M export value · DGFT Verified
MSN Laboratories Private Limited is the #3 Indian exporter of Capecitabine with $7.4M in export value and 323 verified shipments. MSN Laboratories Private Limited holds a 8.4% market share in Capecitabine exports across 8 countries. The company exports 32 pharmaceutical products worth $252.1M across 15 therapeutic categories.
MSN Laboratories Private Limited — Capecitabine Export Profile: Buyers & Destinations
Where Does MSN Laboratories Private Limited Export Capecitabine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $6.0M | 280 | 87.4% |
| UNITED STATES OF AMERICA | $315.9K | 14 | 4.6% |
| PERU | $302.9K | 11 | 4.4% |
| UNITED ARAB EMIRATES | $131.8K | 4 | 1.9% |
| SAUDI ARABIA | $63.4K | 3 | 0.9% |
| KENYA | $33.4K | 7 | 0.5% |
| DOMINICAN REPUBLIC | $12.2K | 2 | 0.2% |
| BARBADOS | $6.9K | 1 | 0.1% |
| NEPAL | $967 | 1 | 0.0% |
MSN Laboratories Private Limited exports Capecitabine to 9 countries. The largest destination is UNITED STATES accounting for 87.4% of MSN Laboratories Private Limited's Capecitabine shipments, followed by UNITED STATES OF AMERICA (4.6%) and PERU (4.4%). These destinations reflect MSN Laboratories Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Capecitabine from MSN Laboratories Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE ORDER OF | UNITED STATES | $3.8M | 182 |
| NOVADOZ PHARMACEUTICALS LLC | UNITED STATES | $2.6M | 117 |
| TO THE ORDER | UNITED STATES | $199.5K | 6 |
| MSN LABS PERU SAC | PERU | $119.7K | 4 |
| MS PHARMA-KSA (MSPS) | SAUDI ARABIA | $63.4K | 3 |
| 'TO THE ORDER | UNITED ARAB EMIRATES | $50.0K | 1 |
| TO THE ORDER MSN LABS PERU SAC CAL | PERU | $33.7K | 2 |
| RIPPLE PHARMACEUTICALS LIMITED | KENYA | $31.4K | 6 |
| TO THE ORDER OF., | BARBADOS | $6.9K | 1 |
| DKM PHARMACEUTICALS PVT LTD | NEPAL | $967 | 1 |
MSN Laboratories Private Limited supplies Capecitabine to 10 buyers globally. The largest buyer is TO THE ORDER OF (UNITED STATES), followed by NOVADOZ PHARMACEUTICALS LLC (UNITED STATES) and TO THE ORDER (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Capecitabine Export Value and How Much Does MSN Laboratories Private Limited Contribute?
India exported $32.0M worth of Capecitabine through 2,246 shipments from 216 suppliers to 123 countries, serving 516 buyers globally. MSN Laboratories Private Limited contributes $7.4M to this total, accounting for 8.4% of India's Capecitabine exports. MSN Laboratories Private Limited ships Capecitabine to 9 countries through 10 buyers.
What Is the Average Shipment Value for MSN Laboratories Private Limited's Capecitabine Exports?
MSN Laboratories Private Limited's average Capecitabine shipment value is $23.0K per consignment, based on 323 shipments totaling $7.4M. The largest destination is UNITED STATES (87.4% of MSN Laboratories Private Limited's Capecitabine exports).
How Does MSN Laboratories Private Limited Compare to Other Indian Capecitabine Exporters?
MSN Laboratories Private Limited ranks #3 among 216 Indian Capecitabine exporters with a 8.4% market share. The top 3 exporters are MSN LABORATORIES PRIVATE LIMITED ($7.4M), INTAS PHARMACEUTICALS LIMITED ($5.0M), EUGIA PHARMA SPECIALITIES LIMITED ($4.0M). MSN Laboratories Private Limited processed 323 shipments to 8 destination countries.
What Capecitabine Formulations Does MSN Laboratories Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| MSN PHARMA CAPECITABINE TABLETS USP 500M | $2.3M | 110 |
| MSN PHARMA CAPECITABINE TABLETS USP 500 | $444.8K | 21 |
| MSN PHARMA CAPECITABINE TABLETS USP 500MG | $282.6K | 14 |
| CAPECITABINE TABLETS USP 500MG (NOVADOZ)(120 S) | $235.2K | 11 |
| CAPECITABINE TABLETS USP 500MG(NOVADOZ) | $182.4K | 9 |
| CAPECITABINE TABLETS USP 500MG (NOVADOZ)NDC NUMBER 72205-007-92 | $166.6K | 4 |
| CAPECITABINE TABLETS USP 500MG (NOVADOZ) | $157.1K | 6 |
| CAPECITABINE TABLETS USP 500MG NOVADOZ | $155.0K | 7 |
| CAPECITABINE TABLETS USP 500MG NOVADOZ120 S | $151.2K | 7 |
| CAPECITABINE TABLETS USP 500MG (NOVADOZ)(3902 X 120'S PACK = 468240 NOS )NOS | $102.3K | 3 |
MSN Laboratories Private Limited exports 91 distinct Capecitabine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is MSN PHARMA CAPECITABINE TABLETS USP 500M with 110 shipments worth $2.3M.
Regulatory Requirements: Exporting Capecitabine to Key Markets
What MSN Laboratories Private Limited must comply with to export Capecitabine to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does MSN Laboratories Private Limited Compare to Nearest Capecitabine Exporters?
Exporters ranked immediately above and below #3 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | MSN LABORATORIES PRIVATE LIMITED ★ | $7.4M | 323 | 8 | $23.0K |
| 5 | INTAS PHARMACEUTICALS LIMITED | $5.0M | 200 | 18 | $25.1K |
| 4 | EUGIA PHARMA SPECIALITIES LIMITED | $4.0M | 80 | 7 | $50.0K |
MSN Laboratories Private Limited ranks #3 among 216 Indian Capecitabine exporters. Average shipment value of $23.0K compared to the market average of $148.1K. The closest competitors by value are INTAS PHARMACEUTICALS LIMITED and EUGIA PHARMA SPECIALITIES LIMITED.
Which Indian Ports Ship Capecitabine Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 359 | 16.0% |
| SAHAR AIR CARGO ACC (INBOM4) | 283 | 12.6% |
| DELHI AIR CARGO ACC (INDEL4) | 233 | 10.4% |
| HYDERABAD ICD (INSNF6) | 173 | 7.7% |
| HYDERABAD AIR | 154 | 6.9% |
| DELHI AIR | 142 | 6.3% |
| HYDERABAD ACC (INHYD4) | 89 | 4.0% |
| Bombay Air | 80 | 3.6% |
What Other Advanced Oncology Products Does MSN Laboratories Private Limited Export?
MSN Laboratories Private Limited also exports these advanced oncology products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on MSN Laboratories Private Limited's Capecitabine Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like MSN Laboratories. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major shipping lines to alter routes. This has resulted in extended transit times by 10–20 days and a 40–50% increase in freight rates on key India–Europe routes, impacting the timely delivery of pharmaceutical products. (livemint.com)
Conversely, the ongoing US-China trade tensions have prompted the United States to diversify its pharmaceutical supply chain, potentially benefiting Indian exporters. However, the imposition of tariffs on Indian pharmaceutical products poses a risk to export volumes, as higher tariffs can lead to increased costs and reduced competitiveness in the US market. (orfonline.org)
In the European Union, compliance with the Falsified Medicines Directive (FMD) requires stringent serialization and traceability measures. For companies like MSN Laboratories, adhering to these regulations is crucial to maintain market access and ensure the integrity of their supply chain.
MSN Laboratories Private Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The U.S. Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practice (EU GMP) guidelines set rigorous quality benchmarks. Any lapses can lead to import bans, product recalls, and reputational damage.
MSN Laboratories' recent legal challenges, such as the patent litigation with Exelixis, Inc., highlight the importance of robust regulatory and intellectual property strategies. Ensuring compliance with evolving quality requirements and proactively addressing regulatory challenges are essential for sustaining export growth and market credibility.
About MSN Laboratories Private Limited
MSN Laboratories Private Limited exports 32 products worth $252.1M. Beyond Capecitabine, top products include Atorvastatin, Rosuvastatin, Ras, Oseltamivir, Calcium. View the complete MSN Laboratories Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Capecitabine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Capecitabine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: MSN Laboratories Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 323 individual customs records matching MSN Laboratories Private Limited exporting Capecitabine, covering 91 formulations to 9 countries via 10 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 123+ countries, 516+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Capecitabine Export Data from MSN Laboratories Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for MSN Laboratories Private Limited's Capecitabine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
MSN Laboratories Private Limited
Full Company Profile →
32 products · $252.1M total trade · 15 categories
Capecitabine Stats
Company Overview
Top Products by MSN Laboratories Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for MSN Laboratories Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Capecitabine. For current shipment-level data, contact TransData Nexus.